Clinical Trial Update: Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing BST-CarGel to microfracture alone for recovery from distal femoral cartilage lesions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defects of the Knee
• Knee Osteoarthritis

Drugs mentioned

• BST CarGel
• Microfracture (surgical microfracture)

Snippet

Sponsor: Piramal Healthcare Canada Ltd | Conditions: Traumatic; Lesion, Degenerative Lesion of Articular Cartilage of Knee | Phase 4 | Status: TERMINATED